Edible and cation-free kiwi fruit derived vesicles mediated EGFR-targeted siRNA delivery to inhibit multidrug resistant lung cancer

Abstract Clinically, activated EGFR mutation associated chemo-drugs resistance has severely threaten NSCLC patients. Nanoparticle based small interfering RNA (siRNA) therapy representing another promising alternative by silencing specific gene while still suffered from charge associated toxicity, st...

Full description

Bibliographic Details
Main Authors: Haoying Huang, Xiaohan Yi, Qingyun Wei, Mengyuan Li, Xueting Cai, Yan Lv, Ling Weng, Yujie Mao, Weiwei Fan, Mengmeng Zhao, Zhongpei Weng, Qing Zhao, Kewei Zhao, Meng Cao, Jing Chen, Peng Cao
Format: Article
Language:English
Published: BMC 2023-02-01
Series:Journal of Nanobiotechnology
Subjects:
Online Access:https://doi.org/10.1186/s12951-023-01766-w
_version_ 1811165703201357824
author Haoying Huang
Xiaohan Yi
Qingyun Wei
Mengyuan Li
Xueting Cai
Yan Lv
Ling Weng
Yujie Mao
Weiwei Fan
Mengmeng Zhao
Zhongpei Weng
Qing Zhao
Kewei Zhao
Meng Cao
Jing Chen
Peng Cao
author_facet Haoying Huang
Xiaohan Yi
Qingyun Wei
Mengyuan Li
Xueting Cai
Yan Lv
Ling Weng
Yujie Mao
Weiwei Fan
Mengmeng Zhao
Zhongpei Weng
Qing Zhao
Kewei Zhao
Meng Cao
Jing Chen
Peng Cao
author_sort Haoying Huang
collection DOAJ
description Abstract Clinically, activated EGFR mutation associated chemo-drugs resistance has severely threaten NSCLC patients. Nanoparticle based small interfering RNA (siRNA) therapy representing another promising alternative by silencing specific gene while still suffered from charge associated toxicity, strong immunogenicity and poor targetability. Herein, we reported a novel EGFR-mutant NSCLC therapy relying on edible and cation-free kiwi-derived extracellular vesicles (KEVs), which showed sevenfold enhancement of safe dosage compared with widely used cationic liposomes and could be further loaded with Signal Transducer and Activator of Transcription 3 interfering RNA (siSTAT3). siSTAT3 loaded KEVs (STAT3/KEVs) could be easily endowed with EGFR targeting ability (STAT3/EKEVs) and fluorescence by surface modification with tailor-making aptamer through hydrophobic interaction. STAT3/EKEVs with a controlled size of 186 nm displayed excellent stability, high specificity and good cytotoxicity towards EGFR over-expressing and mutant PC9-GR4-AZD1 cells. Intriguingly, the systemic administration of STAT3/EKEVs significantly suppressed subcutaneous PC9-GR4-AZD1 tumor xenografts in nude mice by STAT3 mediated apoptosis. This safe and robust KEVs has emerged as the next generation of gene delivery platform for NSCLC therapy after multiple drug-resistance. Graphical Abstract
first_indexed 2024-04-10T15:42:04Z
format Article
id doaj.art-70d7edf95a1743eba2f567191b4077e6
institution Directory Open Access Journal
issn 1477-3155
language English
last_indexed 2024-04-10T15:42:04Z
publishDate 2023-02-01
publisher BMC
record_format Article
series Journal of Nanobiotechnology
spelling doaj.art-70d7edf95a1743eba2f567191b4077e62023-02-12T12:21:30ZengBMCJournal of Nanobiotechnology1477-31552023-02-0121111410.1186/s12951-023-01766-wEdible and cation-free kiwi fruit derived vesicles mediated EGFR-targeted siRNA delivery to inhibit multidrug resistant lung cancerHaoying Huang0Xiaohan Yi1Qingyun Wei2Mengyuan Li3Xueting Cai4Yan Lv5Ling Weng6Yujie Mao7Weiwei Fan8Mengmeng Zhao9Zhongpei Weng10Qing Zhao11Kewei Zhao12Meng Cao13Jing Chen14Peng Cao15School of Pharmacy, Nanjing University of Chinese MedicineSchool of Pharmacy, Nanjing University of Chinese MedicineSchool of Pharmacy, Nanjing University of Chinese MedicineSchool of Pharmacy, Nanjing University of Chinese MedicineSchool of Pharmacy, Nanjing University of Chinese MedicineSchool of Pharmacy, Nanjing University of Chinese MedicineSchool of Pharmacy, Nanjing University of Chinese MedicineSchool of Pharmacy, Nanjing University of Chinese MedicineAffiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese MedicineSchool of Pharmacy, Nanjing University of Chinese MedicineGaoyou Hospital of Traditional Chinese MedicineGuangzhou Key Laboratory of Chinese Medicine Research on Prevention and Treatment of Osteoporosis, The Third Affiliated Hospital of Guangzhou University of Chinese MedicineGuangzhou Key Laboratory of Chinese Medicine Research on Prevention and Treatment of Osteoporosis, The Third Affiliated Hospital of Guangzhou University of Chinese MedicineSchool of Pharmacy, Nanjing University of Chinese MedicineSchool of Pharmacy, Nanjing University of Chinese MedicineSchool of Pharmacy, Nanjing University of Chinese MedicineAbstract Clinically, activated EGFR mutation associated chemo-drugs resistance has severely threaten NSCLC patients. Nanoparticle based small interfering RNA (siRNA) therapy representing another promising alternative by silencing specific gene while still suffered from charge associated toxicity, strong immunogenicity and poor targetability. Herein, we reported a novel EGFR-mutant NSCLC therapy relying on edible and cation-free kiwi-derived extracellular vesicles (KEVs), which showed sevenfold enhancement of safe dosage compared with widely used cationic liposomes and could be further loaded with Signal Transducer and Activator of Transcription 3 interfering RNA (siSTAT3). siSTAT3 loaded KEVs (STAT3/KEVs) could be easily endowed with EGFR targeting ability (STAT3/EKEVs) and fluorescence by surface modification with tailor-making aptamer through hydrophobic interaction. STAT3/EKEVs with a controlled size of 186 nm displayed excellent stability, high specificity and good cytotoxicity towards EGFR over-expressing and mutant PC9-GR4-AZD1 cells. Intriguingly, the systemic administration of STAT3/EKEVs significantly suppressed subcutaneous PC9-GR4-AZD1 tumor xenografts in nude mice by STAT3 mediated apoptosis. This safe and robust KEVs has emerged as the next generation of gene delivery platform for NSCLC therapy after multiple drug-resistance. Graphical Abstracthttps://doi.org/10.1186/s12951-023-01766-wKiwiExtracellular vesiclesRNA aptamersTargeted siRNA deliveryNon-small cell lung cancerDrug resistance
spellingShingle Haoying Huang
Xiaohan Yi
Qingyun Wei
Mengyuan Li
Xueting Cai
Yan Lv
Ling Weng
Yujie Mao
Weiwei Fan
Mengmeng Zhao
Zhongpei Weng
Qing Zhao
Kewei Zhao
Meng Cao
Jing Chen
Peng Cao
Edible and cation-free kiwi fruit derived vesicles mediated EGFR-targeted siRNA delivery to inhibit multidrug resistant lung cancer
Journal of Nanobiotechnology
Kiwi
Extracellular vesicles
RNA aptamers
Targeted siRNA delivery
Non-small cell lung cancer
Drug resistance
title Edible and cation-free kiwi fruit derived vesicles mediated EGFR-targeted siRNA delivery to inhibit multidrug resistant lung cancer
title_full Edible and cation-free kiwi fruit derived vesicles mediated EGFR-targeted siRNA delivery to inhibit multidrug resistant lung cancer
title_fullStr Edible and cation-free kiwi fruit derived vesicles mediated EGFR-targeted siRNA delivery to inhibit multidrug resistant lung cancer
title_full_unstemmed Edible and cation-free kiwi fruit derived vesicles mediated EGFR-targeted siRNA delivery to inhibit multidrug resistant lung cancer
title_short Edible and cation-free kiwi fruit derived vesicles mediated EGFR-targeted siRNA delivery to inhibit multidrug resistant lung cancer
title_sort edible and cation free kiwi fruit derived vesicles mediated egfr targeted sirna delivery to inhibit multidrug resistant lung cancer
topic Kiwi
Extracellular vesicles
RNA aptamers
Targeted siRNA delivery
Non-small cell lung cancer
Drug resistance
url https://doi.org/10.1186/s12951-023-01766-w
work_keys_str_mv AT haoyinghuang edibleandcationfreekiwifruitderivedvesiclesmediatedegfrtargetedsirnadeliverytoinhibitmultidrugresistantlungcancer
AT xiaohanyi edibleandcationfreekiwifruitderivedvesiclesmediatedegfrtargetedsirnadeliverytoinhibitmultidrugresistantlungcancer
AT qingyunwei edibleandcationfreekiwifruitderivedvesiclesmediatedegfrtargetedsirnadeliverytoinhibitmultidrugresistantlungcancer
AT mengyuanli edibleandcationfreekiwifruitderivedvesiclesmediatedegfrtargetedsirnadeliverytoinhibitmultidrugresistantlungcancer
AT xuetingcai edibleandcationfreekiwifruitderivedvesiclesmediatedegfrtargetedsirnadeliverytoinhibitmultidrugresistantlungcancer
AT yanlv edibleandcationfreekiwifruitderivedvesiclesmediatedegfrtargetedsirnadeliverytoinhibitmultidrugresistantlungcancer
AT lingweng edibleandcationfreekiwifruitderivedvesiclesmediatedegfrtargetedsirnadeliverytoinhibitmultidrugresistantlungcancer
AT yujiemao edibleandcationfreekiwifruitderivedvesiclesmediatedegfrtargetedsirnadeliverytoinhibitmultidrugresistantlungcancer
AT weiweifan edibleandcationfreekiwifruitderivedvesiclesmediatedegfrtargetedsirnadeliverytoinhibitmultidrugresistantlungcancer
AT mengmengzhao edibleandcationfreekiwifruitderivedvesiclesmediatedegfrtargetedsirnadeliverytoinhibitmultidrugresistantlungcancer
AT zhongpeiweng edibleandcationfreekiwifruitderivedvesiclesmediatedegfrtargetedsirnadeliverytoinhibitmultidrugresistantlungcancer
AT qingzhao edibleandcationfreekiwifruitderivedvesiclesmediatedegfrtargetedsirnadeliverytoinhibitmultidrugresistantlungcancer
AT keweizhao edibleandcationfreekiwifruitderivedvesiclesmediatedegfrtargetedsirnadeliverytoinhibitmultidrugresistantlungcancer
AT mengcao edibleandcationfreekiwifruitderivedvesiclesmediatedegfrtargetedsirnadeliverytoinhibitmultidrugresistantlungcancer
AT jingchen edibleandcationfreekiwifruitderivedvesiclesmediatedegfrtargetedsirnadeliverytoinhibitmultidrugresistantlungcancer
AT pengcao edibleandcationfreekiwifruitderivedvesiclesmediatedegfrtargetedsirnadeliverytoinhibitmultidrugresistantlungcancer